- Home
- SOUN vs BPMC Comparison
SOUN vs BPMC Comparison
Compare SOUN & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOUN
- BPMC
- Stock Information
- Founded
- SOUN 2005
- BPMC 2008
- Country
- SOUN United States
- BPMC United States
- Employees
- SOUN N/A
- BPMC N/A
- Industry
- SOUN EDP Services
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- SOUN Technology
- BPMC Health Care
- Exchange
- SOUN Nasdaq
- BPMC Nasdaq
- Market Cap
- SOUN 5.3B
- BPMC 5.9B
- IPO Year
- SOUN N/A
- BPMC 2015
- Fundamental
- Price
- SOUN $22.40
- BPMC $93.42
- Analyst Decision
- SOUN Buy
- BPMC Buy
- Analyst Count
- SOUN 6
- BPMC 20
- Target Price
- SOUN $9.92
- BPMC $120.79
- AVG Volume (30 Days)
- SOUN 90.8M
- BPMC 587.2K
- Earning Date
- SOUN 11-12-2024
- BPMC 10-30-2024
- Dividend Yield
- SOUN N/A
- BPMC N/A
- EPS Growth
- SOUN N/A
- BPMC N/A
- EPS
- SOUN N/A
- BPMC N/A
- Revenue
- SOUN $67,297,000.00
- BPMC $434,415,000.00
- Revenue This Year
- SOUN $86.49
- BPMC $108.09
- Revenue Next Year
- SOUN $97.20
- BPMC $39.34
- P/E Ratio
- SOUN N/A
- BPMC N/A
- Revenue Growth
- SOUN 76.05
- BPMC 100.93
- 52 Week Low
- SOUN $1.62
- BPMC $72.24
- 52 Week High
- SOUN $19.97
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- SOUN 84.49
- BPMC 54.99
- Support Level
- SOUN $12.70
- BPMC $91.88
- Resistance Level
- SOUN $19.97
- BPMC $97.44
- Average True Range (ATR)
- SOUN 2.13
- BPMC 2.60
- MACD
- SOUN 0.89
- BPMC -0.12
- Stochastic Oscillator
- SOUN 91.29
- BPMC 66.49
About SOUN SoundHound AI Inc
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.